We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Shuguang Ma - Senior Principal Scientist (Technology), Drug Metabolism & Pharmacokinetics

Shuguang Ma

Senior Principal Scientist (Technology), Drug Metabolism & Pharmacokinetics

"I'm inspired in discovering and developing potential new drugs to treat serious diseases with unmet medical needs."
Years at Genentech
Publications at Genentech

I joined Genentech in 2011 as a Scientist after worked 10 years at other pharmaceutical and biotechnology companies. I currently lead the development biotransformation group in support of small molecule drug development. We focus on characterizing the absorption, distribution, metabolism, elimination properties of small molecule drug candidates using state-of-the-art and innovative technologies. I feel incredibly fortunate to have the opportunity working at such a great place with very talented and passionate scientists.

Featured Publication

Mixed Matrix Method Provides A Reliable Metabolite Exposure Comparison for Assessment of Metabolites in Safety Testing (MIST).

Drug Metab Lett. 2017 Nov 17;11(1):21-28.

Takahashi RH, Khojasteh C, Wright M, Hop CECA, Ma S.